Neurelis Revenue and Competitors
Estimated Revenue & Valuation
- Neurelis's estimated annual revenue is currently $48.2M per year.
- Neurelis's estimated revenue per employee is $251,250
- Neurelis's total funding is $206.1M.
Employee Data
- Neurelis has 192 Employees.
- Neurelis grew their employee count by 25% last year.
Neurelis's People
| Name | Title | Email/Phone |
|---|---|---|
1 | CEO and Co-founder | Reveal Email/Phone |
2 | COO & CFO | Reveal Email/Phone |
3 | VP Marketing and Operations | Reveal Email/Phone |
4 | VP, Commercial Operations | Reveal Email/Phone |
5 | SVP-Regulatory Affairs & Quality Assurance | Reveal Email/Phone |
6 | VP Regulatory Affairs | Reveal Email/Phone |
7 | SVP - Strategic Initiatives | Reveal Email/Phone |
8 | SVP Corporate Development | Reveal Email/Phone |
9 | Senior Director Scientific Operations | Reveal Email/Phone |
10 | Market Development Director | Reveal Email/Phone |
Neurelis Competitors & AlternativesAdd Company
| Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
|---|---|---|---|---|---|
#1 | $102.7M | 511 | 25% | N/A | N/A |
#2 | $0.4M | 2 | 0% | N/A | N/A |
#3 | $38.6M | 192 | 3% | N/A | N/A |
#4 | $35M | 127 | 2% | $62.5M | N/A |
#5 | $36.6M | 182 | 18% | N/A | N/A |
#6 | $131.9M | 656 | -3% | N/A | N/A |
#7 | $133.5M | 664 | N/A | N/A | N/A |
#8 | $72.8M | 362 | -4% | N/A | N/A |
#9 | $551.9M | 1716 | -2% | N/A | N/A |
#10 | $11.7M | 58 | 12% | N/A | N/A |
What Is Neurelis?
Neurelis, Inc. is a privately-held San Diego-based specialty pharmaceutical company devoted to developing treatment options for epilepsy, while also investigating new treatment options for the unmet needs of central nervous system (CNS) disorders. See our community guidelines: https://bit.ly/2HqkNGM
keywords:N/A
$206.1M
Total Funding
192
Number of Employees
$48.2M
Revenue (est)
25%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Neurelis News
NEURELIS EXPANDS INTELLECTUAL PROPERTY ESTATE FOR VALTOCO®, A PATIENT-CENTRIC NASAL SPRAY FOR ACUTE TREATMENT OF EPISODES OF FREQUENT...
Neurelis, Inc., is a commercial-stage neuroscience company focused on the development and commercialization of therapeutics for the treatment of...
Neurelis is slated to present three abstracts at the meeting regarding its completed safety study of Valtoco for the treatment of episodes...
Other Companies in San Diego
| Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
|---|---|---|---|---|
#1 | $57M | 192 | -22% | N/A |
#2 | $32M | 194 | N/A | N/A |
#3 | $70.8M | 195 | -9% | N/A |
#4 | $30.2M | 195 | -10% | N/A |
#5 | $45.3M | 196 | N/A | N/A |